Looking Into Hims & Hers Health's Recent Short Interest
Hims & Hers Health's (NYSE:HIMS) short percent of float has risen 20.25% since its last report. The company recently reported that it has 22.13 million shares sold short, which is 11.76% of all regula
Midday Overview | Hong Kong stocks opened high and fell low, ChiNext fell more than 1%; wind power stocks rose against the trend, Datang Renewables rose more than 5%.
NIO Inc. fell more than 7% after the earnings report, with an expanded loss in the first quarter and a decrease in the average price and delivery volume of autos.
QIAGEN to Discontinue NeuMoDx, Updates 2024 Forecast
QIAGEN Reaffirms Q2 Outlook, Updates FY24 Adj. EPS Outlook From $2.10+ CER To $2.14+ CER
QIAGEN Reaffirms Q2 Outlook, Updates FY24 Adj. EPS Outlook From $2.10+ CER To $2.14+ CER
Twist Bioscience Preclinical Data Detailing Discovery Of Antibody Targeting Emerging Checkpoint Inhibitor Published In The Journal PLOS ONE
TB206-001 shown to be a high-affinity, cross-reactive humanized antibody antagonist of A2AR with in vivo tumor suppressing activityTB206-001 available for out-licensingTwist Bioscience Corporation (NA
Mid-day Review | The three major indices fluctuated and rebounded, with the semiconductor sector rising and Hua Hong Semi up over 7%.
The Hang Seng Index rose by 0.95%, the Technology Index rose by 1.71%, and the National Index rose by 0.81%. The shipping and ports sector strengthened, with Cosco Shipping Holdings rising by 7%. The golden industrial concept rebounded, with SD Gold rising by over 5%.
Qiagen Launches Digital PCR Assay Design Tool For QIAcuity, Expands Customization Capabilities Of Its Research Platform GeneGlobe
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced the launch of its new digital PCR (dPCR) Custom Assay Design Tool for copy number variation (CNV) analysis for use on its digital
Guggenheim Starts Twist at Buy, Cites Proprietary DNA Synthesis Platform
The Most Crowded Longs and Shorts in U.S. Med-Tech for May - UBS
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts
Throughout the last three months, 6 analysts have evaluated Twist Bioscience (NASDAQ:TWST), offering a diverse set of opinions from bullish to bearish.The table below provides a concise overview of re
Twist Bioscience Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/05/2024 10.42% Guggenheim → $53 Initiates Coverage On → Buy 05/06/2024 0% Scotiabank $43 → $48 Maintain
FDA Reports Limited Availability Of Mounjaro Injections (10 Mg/.5 Ml, 7.5 Mg/.5 Ml, 15 Mg/.5 Ml) Through Q2 2024 - Website
FDA Reports Limited Availability Of Mounjaro Injections (10 Mg/.5 Ml, 7.5 Mg/.5 Ml, 15 Mg/.5 Ml) Through Q2 2024 - Website
Mid-day review | Hong Kong's three major stock indexes rise and fall, mainland real estate stocks rise across the board, Radiance Holdings surges more than 27%.
Hang Seng Index rose 0.22%, ChiNext fell 0.12%, CSI300 rose 0.2%; the concept of contract research organizations in the pharmaceutical industry strengthened, genscript bio rose more than 12%; yankuang energy fell more than 9%.
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.Shares of Stericycle, Inc. (NASDAQ:SRCL) rose sharply during Monday's session after the company inked a deal to be
Kimberly-Clark To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.RBC Capital
Hims & Hers Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/03/2024 12.19% B of A Securities $17.25 → $22 Maintains Buy 05/22/2024 22.39% Canaccord Genuity $20 → $
QIAGEN Launches Rapid GI Infection Test in the US, Approved by FDA
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in the United States. The launch comes after the recent clearance of the syn
Intraday Overview | The three major indices of Hong Kong stocks showed strong performance, with the technical index rising more than 3%; auto stocks led the way, and NIO rose more than 5%
TechNet stocks rebounded; Bilibili rose nearly 5%, Meituan rose more than 4%, Tencent, Ctrip, NetEase, and Xiaomi rose more than 3%, and Alibaba rose nearly 3%.